Differential Expression of MMP2 and TIMP2 in Peripheral Blood Mononuclear Cells After Roux-en-Y Gastric Bypass

Differential Expression of MMP2 and TIMP2 in Peripheral Blood Mononuclear Cells After Roux-en-Y Gastric Bypass

Matrix metalloproteinases (MMP) and their endogenous inhibitor, the tissue inhibitor of metalloproteinases (TIMP), are expressed in many different cell types and play an important role in physiologic and pathological degradation of extracellular matrix (ECM). Starting from these observations and con...

Full description

Bibliographic Details
Main Authors:	Carla Barbosa Nonino, Natália Yumi Noronha, Maysa de Araújo Ferreira-Julio, Lígia Moriguchi Watanabe, Karen Francislaine Cassia, Carolina Ferreira Nicoletti, Caroline Rossi Welendorf, Wilson Salgado Junior, Dorotéia Rossi Silva Souza, Marcela Augusta de Souza Pinhel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-10-01
Series:	Frontiers in Nutrition
Subjects:	gene expression metalloproteinases MMP2 (matrix metalloproteinase-2) TIMP (tissue inhibitors of metallproteinase) bariatric surgery
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2021.628759/full

Similar Items

Tissue inhibitors of metalloproteinases (TIMPs) modulate platelet ADAM10 activity
by: Christine Shu Mei Lee, et al.
Published: (2023-12-01)

The serum levels of circulating matrix metalloproteinase MMP-9, MMP-2/TIMP-2 complex and TIMP-1 do not change significantly during normal pregnancy: a pilot study
by: Ritva Nissi, et al.
Published: (2021-01-01)

The contribution of matrix metalloproteinases and their inhibitors to the development, progression, and rupture of abdominal aortic aneurysms
by: Georgia Atkinson, et al.
Published: (2023-09-01)

The Activity of Matrix Metalloproteinases (MMP-2, MMP-9) and Their Tissue Inhibitors (TIMP-1, TIMP-3) in the Cerebral Cortex and Hippocampus in Experimental Acanthamoebiasis
by: Natalia Łanocha-Arendarczyk, et al.
Published: (2018-12-01)

Structure and Function of Human Matrix Metalloproteinases
by: Helena Laronha, et al.
Published: (2020-04-01)

Effects of TIMP1 rs4898 Gene Polymorphism on Early-Onset Preeclampsia Development and Placenta Weight
by: Aleksandra E. Mrozikiewicz, et al.
Published: (2022-07-01)

Challenges in Matrix Metalloproteinases Inhibition
by: Helena Laronha, et al.
Published: (2020-05-01)

Assessment of RANTES, MIP4A, MMP7, MMP9, MMP14, TIMP 1, TIMP 2 and TIMP 3 concentration in the follicular fluid of patients undergoing in vitro fertilization/embryo transfer procedure
by: Rafał Adamczak, et al.
Published: (2023-01-01)

Quantitative Proteomics Reveals Changes Induced by TIMP-3 on Cell Membrane Composition and Novel Metalloprotease Substrates
by: Anna Paola Carreca, et al.
Published: (2021-02-01)

Urinary Exosomal Tissue TIMP and Angiopoietin-1 Are Preoperative Novel Biomarkers of Well-Differentiated Thyroid Cancer
by: Chih-Yuan Wang, et al.
Published: (2022-12-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

The role of MMP-9 and TIMP-1 in nasal polyp formation
by: OK Kahveci, et al.
Published: (2008-11-01)

Metalloproteinases in Endometrial Cancer—Are They Worth Measuring?
by: Kaja Michalczyk, et al.
Published: (2021-11-01)

Diverse functions of matrix metalloproteinases during fibrosis
by: Matthew Giannandrea, et al.
Published: (2014-02-01)

Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment
by: Ruth M. Escalona, et al.
Published: (2022-01-01)

Relationship between matrix metalloproteinases and the occurrence and development of ovarian cancer
by: Y. Zhang, et al.

MMP-2, MMP-9, TIMP-1, and TIMP-2 in the Peripheral Blood of Patients with Differentiated Thyroid Carcinoma
by: Zhang W, et al.
Published: (2019-12-01)

TNF-induced metalloproteinase-9 production is associated with neurological manifestations in HTLV-1-infected individuals
by: Mariele Guerra, et al.
Published: (2022-10-01)

Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition
by: Danièle Taras, et al.
Published: (2006-04-01)

The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment
by: Magdalena Kopańko, et al.
Published: (2024-03-01)

Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases
by: Suellen Herbster, et al.
Published: (2018-09-01)

Urinary Metalloproteinases-9 and -2 and Their Inhibitors TIMP-1 and TIMP-2 are Markers of Early and Long-Term Graft Function After Renal Transplantation
by: Ewa Kwiatkowska, et al.
Published: (2016-05-01)

Imbalance of Pulmonary Microvascular Endothelial Cell-Expression of Metalloproteinases and Their Endogenous Inhibitors Promotes Septic Barrier Dysfunction
by: Devika P. Jayawardena, et al.
Published: (2023-04-01)

Evaluation of MMP-9, IL-6, TNF-α levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease
by: Tooran Akbari, et al.
Published: (2023-12-01)

Matrix Metalloproteinases and Their Inhibitors as Potential Prognostic Biomarkers in Head and Neck Cancer after Radiotherapy
by: Gabriel Fornieles, et al.
Published: (2023-12-01)

Matrix Metalloproteinases in Dental and Periodontal Tissues and Their Current Inhibitors: Developmental, Degradational and Pathological Aspects
by: Moataz Elgezawi, et al.
Published: (2022-08-01)

The Effects of Exercise on Plaque Volume and Composition in a Mouse Model of Early and Late Life Atherosclerosis
by: Kelly M. Stanton, et al.
Published: (2022-03-01)

MMPs and TIMPs expression in facial tissue of children with cleft lip and palate
by: Liene Smane-Filipova, et al.
Published: (2016-12-01)

Expression of Tissue Inhibitors of Metalloproteinases (TIMP-1, TIMP-2, TIMP-3, TIMP-4) in Blood Serum of Patients with Keratoconus
by: Marta Nowak-Wąs, et al.
Published: (2024-02-01)

The effect of resveratrol on expression of matrix metalloproteinase 9 and its tissue inhibitors in vascular smooth muscle cells
by: Effat Farrokhi, et al.
Published: (2018-07-01)

Relationship between the Levels of MMP-9, TIMP-1, and Zinc in Biological Samples of Patients with Carotid Atherosclerosis
by: Zakhro A. Usmanova
Published: (2015-06-01)

Role of Matrix Metalloproteinases and Their Inhibitors in Locally Invasive Papillary Thyroid Cancer
by: Irena Ivković, et al.
Published: (2022-12-01)

Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis
by: Jordana Maria Azevedo Martins, et al.
Published: (2020-07-01)

Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines
by: Yihe Wang, et al.
Published: (2022-08-01)

Relationships of MMP-9 and TIMP-1 proteins with chronic obstructive pulmonary disease risk: A systematic review and meta-analysis
by: Yangxue Li, et al.
Published: (2016-01-01)

Relationships between Circulating Matrix Metalloproteinases, Tissue Inhibitor TIMP-2, and Renal Function in Patients with Myocarditis
by: Małgorzata Kobusiak-Prokopowicz, et al.
Published: (2021-11-01)

Matrix Metalloproteinase Inhibitors (MMPIs) from Marine Natural Products: the Current Situation and Future Prospects
by: Se-Kwon Kim, et al.
Published: (2009-03-01)

The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer
by: Maciej Szmitkowski, et al.
Published: (2012-04-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Strategies to Target ADAM17 in Disease: From Its Discovery to the iRhom Revolution
by: Matteo Calligaris, et al.
Published: (2021-02-01)